PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA), submitted under the 505(b)(2) regulatory…Original Article
FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia
